Skip to main content
SpringerLink
Log in

Monobactams and carbapenems for treatment of intraabdominal infections

  • Addendum
  • Published:
Infection Aims and scope Submit manuscript

Summary

During the last decade improved clinical and microbiological methods have resulted in the realization that most intraabdominal infections involve both aerobic and anaerobic bacteria. Papers on the use of different antimicrobial agents directed against the polymicrobial flora of the infected site have been published. In this paper the use of monobactams and carbapenems for treatment of intraabdominal infections is reviewed. The review is based on data published since 1990. Three hundred forty-four patients participated in three trials where aztreonam combined with clindamycin was compared with other antimicrobial agents for treatment of intraabdominal infections. Eighty-six percent of the patients receiving aztreonam plus clindamycin were cured/improved, while 83% of the patients receiving the comparative drugs had favorable outcomes. Eleven trials compared imipenem/cilastatin versus other antimicrobial combinations for therapyof intraabdominal infections. One thousand three hundred seventy-five patients were evaluated in the trials. Eighty percent of patients treated with imipenem/cilastatin had favorable outcomes, while 81% of the patients receiving the comparative drugs were cured/improved. Nine studies including 1,205 patients for evaluation of meropenem versus other antimicrobial agents in the treatment of intraabdominal infections have been published. Cure/improvement was seen in 96% of the patients treated with meropenem and in 91% receiving the comparative drugs. One trial has been published comparing biapenem with imipenem/cilastatin for treatment of intraabdominal infections. Eighty-three patients participated, 65% of the patients in the biapenem group were cured/improved and 68% in the imipenem/cilastatin group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Williams, R. R., Hotchkin, D.: Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections. Rev. Infect. Dis. 13 (1991) S629-S633.

    PubMed  Google Scholar 

  2. Fabian, T. C., Hess, M. M., Croce, M. A., Wilson, R. S., Wilson, S. E., Charland, S. L., Rodman, J. H., Boucher, B. A.: Superiority of aztreonam/ clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. Am. J. Surg. 167 (1994) 291–296.

    Article  PubMed  CAS  Google Scholar 

  3. Barboza, E., del Castillo, M., Yi, A., Gotuzzo, E.: Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections. Surgery 116 (1994) 28–35.

    PubMed  CAS  Google Scholar 

  4. de Lissovoy, G., Elixhauser, A., Luce, B. R., Weschler, J., Mowery, P., Reblando, J., Solomkin, J.: Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intraab-dominal infection. Pharmaco-Economics 4 (1993) 203–214.

    Article  Google Scholar 

  5. Solomkin, J. S., Dellinger, E. P., Christou, N., Busuttil, R. W.: Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/c clindamycin for intraabdominal infections. Ann. Surg. 212 (1990) 581–591.

    Article  PubMed  CAS  Google Scholar 

  6. Jhee, S. S., Gill, M. A., Yellin, A. E., Berne, T. V., Heseltine, P. N., Appleman, M. D.: Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of patients with intrabdominal infections. Clin. Therapeut. 17 (1995) 126–135.

    Article  CAS  Google Scholar 

  7. Poenaru, D., Santis, M. D., Christou, N. V.: Imipenem versus tobramycin—antianaerobe therapy in intraabdominal infections. Can. J. Surg. 33 (1990) 415–422.

    PubMed  CAS  Google Scholar 

  8. Uhari, M., Seppänen, J., Heikkinen, E.: Imipenem-cilastatin versus tobramycin-metronidazole for appendicitis-related infections. Pediatr. Infect. Dis. J. 11 (1992) 445–450.

    Article  PubMed  CAS  Google Scholar 

  9. Solomkin, J. S., Reinhart, H. H., Dellinger, E. P., Bohnen, J. M., Rotstein, O. D., Vogel, S. B., Simms, H. H., Hill, C. S., Bjornson, H. S., Haverstock, D. C., Coulter, H. O., Echols, R. M.: Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intraabdominal infections. Ann. Surg. 223 (1996) 303–315.

    Article  PubMed  CAS  Google Scholar 

  10. Cakmakci, M., Stern, A., Schilling, J., Christen, D., Roggo, A., Geroulanos, S.: Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections. Drugs Exptl. Clin. Res. 19 (1993) 223–227.

    CAS  Google Scholar 

  11. Brismar, B., Malmborg, A. S., Tunevall, G., Wretlind, B., Bergman, L., Mentzing, L. O., Nyström, P. O., Kihlström, E., Bäckstrand, B., Skau, T., Kasholm-Tengve, B., Sjöberg, L., Olsson-Liljequist, B., Tally, F. P., Gatenbeck, L., Eklund, A. E., Nord, C. E.: Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrob. Agents Chemother. 36 (1992) 2766–2773.

    PubMed  CAS  Google Scholar 

  12. Niinikoski, J., Havia, T., Alhava, E., Paakkonen, M., Miettinen, P., Kivilaakso, E., Haapiainen, R., Matikainen, M., Laitinen, S.: Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intraabdominal infections. Surg., Gynecol., Obstetr. 176 (1993) 255–261.

    CAS  Google Scholar 

  13. de Groot, H. G., Hustinx, P. A., Lampe, A. S., Oosterwijk, W. M.: Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intraabdominal infections. J. Antimicrob. Chemother. 32 (1993) 491–500.

    Article  PubMed  Google Scholar 

  14. Hall-Angerås, M., Darle, N., Hamnström, K., Ekelund, M., Engström, L., Takala, J., Viste, A., Bendix Holme, J.: A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intraabdominal infections. Scand. J. Infect. Dis. 28 (1996) 513–518.

    Google Scholar 

  15. Berne, T. V., Yellin, A. E., Appleman, M. D., Heseltine, T. V., Gill, M. A.: Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis. J. Am. Coll. Surg. 182 (1996) 403–407.

    PubMed  CAS  Google Scholar 

  16. Wilson, S. E.: Results of a randomized multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intraab-dominal infections. Clin. Infect. Dis. 24 (1997) S197-S206.

    PubMed  CAS  Google Scholar 

  17. Pitkin, D., Sheikh, W., Wilson, S. E., Hemsell, D., Nichols, R., Nadler, H., Dowzicky, M.: Comparison of the activity of meropenem with that of other agents in the treatment of intraabdominal obstetric/gynecologic and skin and soft tissue infections. Clin. Infect. Dis. 20 (1995) S372-S375.

    PubMed  Google Scholar 

  18. Kanellakopolou, K., Giamarellou, H., Papadothomakos, P., Tsipras, H., Chloroyiannis, J., Theakou, R., Sfikakis, P.: Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery. Eur. J. Clin. Microbiol. Infect. Dis. 12 (1993) 449–453.

    Article  Google Scholar 

  19. Kempf, P., Bauernfeind, A., Müller, A., Blum, J.: Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intraabdominal infections. Infection 24 (1996) 473–479.

    Article  PubMed  CAS  Google Scholar 

  20. Geroulanos, S. J., The Meropenem Study Group: Meropenem versus imipenem/cilastatin in intraabdominal infections requiring surgery. J. Antimicrob. Chemother. 36 (1995) 191–205.

    PubMed  CAS  Google Scholar 

  21. Condon, R. E., Walker, A. P., Sirinek, K. R., White, P. W., Fabian, T. C., Nichols, R. L., Wilson, S. E.: Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: Results of a prospective randomized double-blind clinical trial. Clin. Infect. Dis. 21 (1995) 544–550.

    PubMed  CAS  Google Scholar 

  22. Huizinga, W. K., Warren, B. L., Baker, L. W., Valleur, P., Pezet, D. M., Hoogkamp-Korstanje, J. A. A., Karran, S. J.: Antibiotic monotherapy with meropenem in the surgical management of intraabdominal infections. J. Antimicrob. Chemother. 36 (1995) 179–189.

    PubMed  CAS  Google Scholar 

  23. Brismar, B., Eklund, A. E., Nord, C. E.: Immune response in patients with intraabdominal infections treated with carbapenems. Int. J. Clin. Pharm. Res. 14 (1994) 111–114.

    CAS  Google Scholar 

  24. Brismar, B., Malmborg, A. S., Tunevall, G., Lindgren, V., Bergman, L., Mentzing, L. O., Nyström, P. O., Ånséhn, S., Bäckstrand, B., Skau, T., Andåker, L., Gustafsson, P. O., Kasholm-Tengve, B., Sjöberg, L., Olsson-Liljequist, B., Eklund, A. E., Nord, C. E.: Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. J. Antimicrob. Chemother. 35 (1995) 139–148.

    Article  PubMed  CAS  Google Scholar 

  25. Brismar, B., Åkerlund, J.-E., Sjöstedt, S., Johansson, C., Törnqvist, A., Bäckstrand, B., Bång, H., Andåker, L., Gustafsson, P.-O., Darle, N., Angerås, M., Falk, A., Tunevall, G., Kasholm-Tengve, B., Skau, T., Nyström, P.-O., Gasslander, T., Hagelbäck, A., Olsson-Liljequist, B., Eklund, A.-E., Nord, C. E.: Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: Report from a Swedish Study Group. Scand. J. Infect. Dis. 28 (1996) 507–512.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division for Anesthesiology, Day Surgery, Emergency Medicine, Operating Theaters and Radiology, Huddinge University Hospital, S-141 86, Huddinge, Sweden

    B. Brismar

  2. Dept. of Immunology, Microbiology, Pathology and Infectious Diseases, Karolinska Institutet, Huddinge University Hospital, S-141 86, Huddinge, Sweden

    C. E. Nord

Authors
  1. B. Brismar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. E. Nord
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brismar, B., Nord, C.E. Monobactams and carbapenems for treatment of intraabdominal infections. Infection 27, 136–147 (1999). https://doi.org/10.1007/BF02560517

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02560517

Keywords

Search

Navigation